Abstract:
:Much has been published on various aspects of data analysis and reporting from clinical trials within the biopharmaceutical environment. This ranges from regulatory guidelines on the format and content of registration dossiers to recommendations on data presentation and the statistical methodologies that are appropriate for the diverse types of data one observes in clinical trials. Little has been written about designing a clinical trial analysis and reporting package that focuses on the decisions that must be made throughout the drug development process. Pharmaceutical companies today are under enormous pressure to develop drugs quickly and (cost-) efficiently. Because of this, drugs often move into the later phases of drug development before evidence from prior phases is completely understood. This provides a challenge to clinical trialists to design and execute a clinical trial programme which can expedite drug development. The statistician, as a clinical trialist, must strive to determine the optimum analytical methodology that facilitates decision making for this clinical trial programme. This paper proposes a new framework for the assessment of efficacy in drug development called the 'one programme, one p-value' framework. This framework will accelerate drug development by providing clear criteria for the decisions which must be made along the way. The 'one programme, one p-value' framework is based on the notion that the clinical trial programme comprises exploratory and confirmatory phases. The use of the likelihood function in the exploratory phase facilitates the decision whether (or when) to move into the confirmatory phase. The confirmatory phase consists of one confirmatory trial with a single hypothesis test of the drug's efficacy; hence 'one p-value'. Sponsor interaction with regulatory agencies is necessary at each decision point. Finally, the paper considers how analysis and reporting of efficacy data can be accomplished from a clinical trial programme as described.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Huster WJ,Enas GGdoi
10.1002/(sici)1097-0258(19980815/30)17:15/16<1829:subject
Has Abstractpub_date
1998-08-15 00:00:00pages
1829-38issue
15-16eissn
0277-6715issn
1097-0258pii
10.1002/(SICI)1097-0258(19980815/30)17:15/16<1829:journal_volume
17pub_type
杂志文章,评审abstract::Shared random effects models have been increasingly common in the joint analyses of repeated measures (e.g. CD4 counts, hemoglobin levels) and a correlated failure time such as death. In this paper we study several shared random effects models in the multi-level repeated measures data setting with dependent failure ti...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3392
更新日期:2008-11-29 00:00:00
abstract::Public health interventions are often designed to target communities defined either geographically (e.g. cities, counties) or socially (e.g. schools or workplaces). The group randomized trial (GRT) is regarded as the gold standard for evaluating these interventions. However, community leaders may object to randomizati...
journal_title:Statistics in medicine
pub_type: 杂志文章,随机对照试验
doi:10.1002/sim.4237
更新日期:2011-07-10 00:00:00
abstract::A stochastic approximation EM algorithm (SAEM) is described for exploratory factor analysis of dichotomous or ordinal variables. The factor structure is obtained from sufficient statistics that are updated during iterations with the Robbins-Monro procedure. Two large-scale simulations are reported that compare accurac...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8217
更新日期:2019-09-20 00:00:00
abstract::Pooling biospecimens prior to performing lab assays can help reduce lab costs, preserve specimens, and reduce information loss when subject to a limit of detection. Because many biomarkers measured in epidemiological studies are positive and right-skewed, proper analysis of pooled specimens requires special methods. I...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6496
更新日期:2015-07-30 00:00:00
abstract::In many medical and health studies, high-dimensional data are often encountered. Principal component analysis (PCA) is a commonly used technique to reduce such data to a few components that includes most of the information provided by the original data. However, PCA is known to be very sensitive to some abnormal obser...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2747
更新日期:2007-06-15 00:00:00
abstract::Randomized clinical trial designs commonly include one or more planned interim analyses. At these times an external monitoring committee reviews the accumulated data and determines whether it is scientifically and ethically appropriate for the study to continue. With failure-time endpoints, it is common to schedule an...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.843
更新日期:2001-07-30 00:00:00
abstract::Instrumental variable is an essential tool for addressing unmeasured confounding in observational studies. Two-stage predictor substitution (2SPS) estimator and two-stage residual inclusion (2SRI) are two commonly used approaches in applying instrumental variables. Recently, 2SPS was studied under the additive hazards...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8071
更新日期:2019-05-10 00:00:00
abstract::A new, intuitive method has recently been proposed to explore treatment-covariate interactions in survival data arising from two treatment arms of a clinical trial. The method is based on constructing overlapping subpopulations of patients with respect to one (or more) covariates of interest and in observing the patte...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3524
更新日期:2009-04-15 00:00:00
abstract::Motivated by a previously published study of HIV treatment, we simulated data subject to time-varying confounding affected by prior treatment to examine some finite-sample properties of marginal structural Cox proportional hazards models. We compared (a) unadjusted, (b) regression-adjusted, (c) unstabilized, and (d) s...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5317
更新日期:2012-08-30 00:00:00
abstract::This paper reviews methods for mapping geographical variation in disease incidence and mortality. Recent results in Bayesian hierarchical modelling of relative risk are discussed. Two approaches to relative risk estimation, along with the related computational procedures, are described and compared. The first is an em...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780110802
更新日期:1992-06-15 00:00:00
abstract::Vaccination in populations can have several kinds of effects. Establishing that vaccination produces population-level effects beyond the direct effects in the vaccinated individuals can have important consequences for public health policy. Formal methods have been developed for study designs and analysis that can esti...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7392
更新日期:2018-01-30 00:00:00
abstract::In medical research, risk difference (RD) and number needed to treat (NNT) measures for survival times have been mainly proposed without consideration of covariates. In this paper, we develop adjusted RD and NNT measures for use in observational studies with survival time outcomes within the framework of the Cox propo...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3793
更新日期:2010-03-30 00:00:00
abstract::Service on the Data Monitoring Committee of the CPEP (Calcium for Pre-eclampsia Prevention) has led us to four conclusions about clinical trials which we should like to present to this gathering of biostatisticians for their reactions: (i) meta-analyses of the pertinent published trials of the same therapy should alwa...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(SICI)1097-0258(19960630)15:12<1263::AID-S
更新日期:1996-06-30 00:00:00
abstract::Surrogate endpoint validation has been well established by the meta-analytical correlation-based approach as outlined in the seminal work of Buyse et al. (Biostatistics, 2000). Surrogacy can be assumed if strong associations on individual and study levels can be demonstrated. Alternatively, if an effect on a true endp...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6778
更新日期:2016-03-30 00:00:00
abstract::In many community-based studies on the incidence of dementia, a target population is screened and a subsample is clinically evaluated at baseline and follow-up. Incidence rates are affected by missed cases at both exams and this complicates the estimation of these rates. Recent work proposes a regression-based techniq...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1577:
更新日期:2000-06-15 00:00:00
abstract::In many chronic diseases, therapy aims to prevent or reduce the frequency of episodes of a disease manifestation, for example cardiac ischaemic episodes or epileptic seizures. Entry criteria for clinical trials typically include a minimum number of episodes within a baseline period, and regression to the mean should b...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780130806
更新日期:1994-04-30 00:00:00
abstract::The problem for assessing biosimilarity and drug interchangeability of follow-on biologics (biosimilar products) is studied. Unlike the generic products, the development of biosimilar products is much more complicated because of fundamental differences in functional structures and manufacturing processes. As a result,...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5571
更新日期:2013-02-10 00:00:00
abstract::The availability of large data sets together with the growth in power and storage capabilities of computers have made the analysis of the spatial distribution of disease rates an increasingly important tool in public health research. Use of existing geographic divisions or groupings tends to result either in unstable ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780121916
更新日期:1993-10-01 00:00:00
abstract::When estimating causal effects, unmeasured confounding and model misspecification are both potential sources of bias. We propose a method to simultaneously address both issues in the form of a semi-parametric sensitivity analysis. In particular, our approach incorporates Bayesian Additive Regression Trees into a two-p...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6973
更新日期:2016-09-10 00:00:00
abstract::During phase III clinical trials in life-threatening disease settings, it is important to ensure that the Data Monitoring Committee (DMC) has exclusive access to the interim efficacy and safety data generated by the data analysis centre, in order to minimize the risk of widespread prejudgement of unreliable trial resu...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1288
更新日期:2002-10-15 00:00:00
abstract::In the presence of confounding, the consistency assumption required for identification of causal effects may be violated due to misclassification of the outcome variable. We introduce an inverse probability weighted approach to rebalance covariates across treatment groups while mitigating the influence of differential...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7522
更新日期:2018-02-10 00:00:00
abstract::Bayesian methods are proposed for analysing matched case-control studies in which a binary exposure variable is sometimes measured with error, but whose correct values have been validated for a random sample of the matched case-control sets. Three models are considered. Model 1 makes few assumptions other than randomn...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2000
更新日期:2005-02-15 00:00:00
abstract::Prevalence data provided by cancer registries are generally biased, since the patients that were diagnosed before the starting of the registry's activity cannot be included in the statistics. The relevance of this incompleteness bias is estimated in this paper. Incidence and relative survival are modelled as parametri...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19970228)16:4<425::aid-sim
更新日期:1997-02-28 00:00:00
abstract::Virtually all clinical trials collect multiple endpoints that are usually correlated. Many methods have been proposed to control the family-wise type I error rate (FWER), but these methods often disregard the correlation among the endpoints, such as the commonly used Bonferroni correction, Holm procedure, Wiens' Bonfe...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4434
更新日期:2012-02-20 00:00:00
abstract::The most popular model used for survival analysis is the proportional hazards regression model proposed by Cox. This is mainly due to its exceptional simplicity. Nevertheless the fundamental assumption of the Cox model is the proportionality of the hazards. For many applications, however, this assumption is doubtful. ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1411
更新日期:2003-04-15 00:00:00
abstract::In the development of a new treatment in oncology, phase II trials play a key role. On the basis of the data obtained during phase II, it is decided whether the treatment should be studied further. Therefore, the decision to be made on the basis of the data of a phase II trial must be as accurate as possible. For ethi...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5585
更新日期:2012-12-30 00:00:00
abstract::This article introduces a global hypothesis test intended for studies with multiple endpoints. Our test makes use of a priori predictions about the direction of the result of each endpoint and we weight these predictions using the sample correlation matrix. The global alternative hypothesis concerns a parameter, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8724
更新日期:2020-12-10 00:00:00
abstract::This work is motivated by a longitudinal study of women and their ectopic pregnancy outcomes in Lund, Sweden. In this article, we review and apply the Liang-Zeger methodology to the Lund ectopic pregnancy data set. We further analyse the ectopic pregnancy data using conditional modelling approaches suggested by Rosner...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19971115)16:21<2403::aid-s
更新日期:1997-11-15 00:00:00
abstract::In the analysis of survival data, there are often competing events that preclude an event of interest from occurring. Regression analysis with competing risks is typically undertaken using a cause-specific proportional hazards model. However, modern alternative methods exist for the analysis of the subdistribution haz...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4123
更新日期:2011-03-15 00:00:00
abstract::The publication of Fisher's correspondence on statistics has shed new light on his views on randomization. Quotations from this correspondence and from other works of Fisher are used to illustrate the role of randomization in clinical trials. It is concluded that Fisher's views not only are coherent but, despite havin...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780130305
更新日期:1994-02-15 00:00:00